Citation Impact
Citing Papers
A small-molecule switch for Golgi sulfotransferases
2004 StandoutNobel
CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
2011
The gut microbiota and host health: a new clinical frontier
2015 Standout
Regulatory T-cell directed therapies in liver diseases
2013 StandoutNobel
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade
2008 Standout
Ischemia and reperfusion—from mechanism to translation
2011 Standout
Imaging beyond the proteome
2012 StandoutNobel
The Stem Region of the Sulfotransferase GlcNAc6ST-1 Is a Determinant of Substrate Specificity
2004 StandoutNobel
Should All Patients with Non–Muscle-Invasive Bladder Cancer Receive Early Intravesical Chemotherapy after Transurethral Resection? The Results of a Prospective Randomised Multicentre Study
2009
Monocyte and macrophage heterogeneity
2005 Standout
Nucleotide signalling during inflammation
2014 StandoutNature
Extracellular adenosine triphosphate and adenosine in cancer
2010
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial
2005
Hypoxia and Inflammation
2011 Standout
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
Glycosylation in Cellular Mechanisms of Health and Disease
2006 Standout
Molecular Aspects of Bladder Cancer
2002
Immediate Post–Transurethral Resection of Bladder Tumor Intravesical Chemotherapy Prevents Non–Muscle-invasive Bladder Cancer Recurrences: An Updated Meta-analysis on 2548 Patients and Quality-of-Evidence Review
2013
CD73: a potent suppressor of antitumor immune responses
2012
Cell-surface enzymes in control of leukocyte trafficking
2005
Enhanced expression of B7-1, B7-2, and intercellular adhesion molecule 1 in sinusoidal endothelial cells by warm ischemia/reperfusion injury in rat liver
2001 StandoutNobel
Dissolution of 2-Microglobulin Amyloid Fibrils by Dimethylsulfoxide
2003
Lymphangiogenesis in development and human disease
2005 StandoutNature
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa–pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?
2015
Immunology of the gut and liver: a love/hate relationship
2008
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
2011 Standout
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer
2014
Bladder cancer
2016 Standout
One Immediate Postoperative Instillation of Chemotherapy in Low Risk Ta, T1 Bladder Cancer Patients. Is it Always Safe?
2004
Alternating Mitomycin C and BCG Instillations versus BCG Alone in Treatment of Carcinoma in Situ of the Urinary Bladder: A Nordic Study
2003
The immunology of stroke: from mechanisms to translation
2011 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guérin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non–Muscle-invasive Bladder Cancer in Intermediate- and High-risk Patients: Final Outcome of CUETO 93009, a Randomized Prospective Trial
2014
PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis
2020 StandoutNobel
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease
2006
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
2008 Standout
P53 as a prognostic marker for bladder cancer: a meta-analysis and review
2005
Sterile inflammation: sensing and reacting to damage
2010 Standout
Mapping the core of the β2-microglobulin amyloid fibril by H/D exchange
2002
Getting to the site of inflammation: the leukocyte adhesion cascade updated
2007 Standout
Long-term Outcome of Patients with Frequently Recurrent Non–muscle-invasive Bladder Carcinoma Treated with One Perioperative Plus Four Weekly Instillations of Mitomycin C Followed by Monthly Bacillus Calmette-Guérin (BCG) or Alternating BCG and Interferon-α2b Instillations: Prospective Randomised FinnBladder-4 Study
2015
Treatment with Soluble VEGF Receptor Reduces Disease Severity in Murine Collagen-Induced Arthritis
2000
Effect of Prophylactic Treatment with Intravesical Epirubicin on Recurrence of Superficial Bladder Cancer—The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG):
2004
High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder
2005
Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation
2006
Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials
2006
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors
2018 StandoutNobel
Re: A Single Instillation of Epirubicin After Transurethral Resection of Bladder Tumors Prevents Only Small Recurrences
2008
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
2011
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
THE PREDICTIVE VALUE OF MUSCULARIS MUCOSAE INVASION AND p53 OVER EXPRESSION ON PROGRESSION OF STAGE T1 BLADDER CARCINOMA
2001
A Single Instillation of Epirubicin After Transurethral Resection of Bladder Tumors Prevents Only Small Recurrences
2007
BACILLUS CALMETTE-GUERIN VERSUS CHEMOTHERAPY FOR THE INTRAVESICAL TREATMENT OF PATIENTS WITH CARCINOMA IN SITU OF THE BLADDER: A META-ANALYSIS OF THE PUBLISHED RESULTS OF RANDOMIZED CLINICAL TRIALS
2005
Protein Misfolding, Functional Amyloid, and Human Disease
2006 Standout
RESULTS OF A RANDOMIZED PHASE III TRIAL OF SEQUENTIAL INTRAVESICAL THERAPY WITH MITOMYCIN C AND BACILLUS CALMETTE-GUERIN VERSUS MITOMYCIN C ALONE IN PATIENTS WITH SUPERFICIAL BLADDER CANCER
1998
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Alternating mitomycin C and bacillus Calmette-Guerin instillation prophylaxis for recurrent papillary (stages Ta to T1) superficial bladder cancer. Finnbladder Group.
1996
3D structure of Alzheimer's amyloid-β(1–42) fibrils
2005 Standout
Bladder Cancer
2020 Standout
A SINGLE IMMEDIATE POSTOPERATIVE INSTILLATION OF CHEMOTHERAPY DECREASES THE RISK OF RECURRENCE IN PATIENTS WITH STAGE Ta T1 BLADDER CANCER: A META-ANALYSIS OF PUBLISHED RESULTS OF RANDOMIZED CLINICAL TRIALS
2004
Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term follow-up.
2007
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Nuclear imaging of inflammation: homing-associated molecules as targets
2013
Antigen Recognition Influences Transendothelial Migration of CD4+ T Cells
1999
Ligands for L-Selectin: Homing, Inflammation, and Beyond
2003
Prospective Validation of the Clinical Usefulness of Reflex Fluorescence In Situ Hybridization Assay in Patients With Atypical Cytology for the Detection of Urothelial Carcinoma of the Bladder
2009
INHIBITION OF BLADDER CARCINOMA CELL ADHESION BY OLIGOPEPTIDE COMBINATIONS IN VITRO AND IN VIVO
2002
A Chemical Reporter Strategy to Probe Glycoprotein Fucosylation
2006 StandoutNobel
Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia‐reperfusion injury
2008
Hypoxia-inducible factor plays a gut-injurious role in intestinal ischemia reperfusion injury
2010 StandoutNobel
Designed amyloid fibers as materials for selective carbon dioxide capture
2013 StandoutNobel
HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury
2010 StandoutNobel
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Alternating Mitomycin C and Bacillus Calmette-Guerin Instillation Prophylaxis For Recurrent Papillary (Stages Ta to T1) Superficial Bladder Cancer
1996
Imaging the glycome
2008 StandoutNobel
INHIBITION OF TUMOR IMPLANTATION BY INTRAVESICAL GEMCITABINE IN A MURINE MODEL OF SUPERFICIAL BLADDER CANCER
2005
A Review of Current Guidelines and Best Practice Recommendations for the Management of Nonmuscle Invasive Bladder Cancer by the International Bladder Cancer Group
2011
Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
2012 Standout
Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical Trials
2002 Standout
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non–Muscle-Invasive Bladder Cancer on Tumor Recurrence
2018
CLEVER-1 mediates lymphocyte transmigration through vascular and lymphatic endothelium
2004
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of Pertti Rajala being referenced
IFN-α Induced Adenosine Production on the Endothelium: A Mechanism Mediated by CD73 (Ecto-5′-Nucleotidase) Up-Regulation
2004
Prognostic Value of MIB-1 Score, p53, EGFr, Mitotic Index and Papillary Status in Primary Superficial (Stage pTa/T1) Bladder Cancer: A Prospective Comparative Study
1999
Differences Between Local and Review Urinary Cytology in Diagnosis of Bladder Cancer. An Interobserver Multicenter Analysis
2002
Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion.
1997
Factors Explaining Recurrence in Patients Undergoing Chemoimmunotherapy Regimens for Frequently Recurring Superficial Bladder Carcinoma
2002
TRANSURETHRAL RESECTION WITH PERIOPERATIVE INSTILLATION OF INTERFERON-alpha OR EPIRUBICIN FOR THE PROPHYLAXIS OF RECURRENT PRIMARY SUPERFICIAL BLADDER CANCER: A PROSPECTIVE RANDOMIZED MULTICENTER STUDY-FINNBLADDER III
1999
Cytostatic effect of different strains of Bacillus Calmette-Gu�rin on human bladder cancer cells in vitro alone and in combination with mitomycin C and Interferon-?
1992
Evaluation of p21 WAF1/CIP1 and cyclin D 1 expression in the progression of superficial bladder cancer
2000
Alternating Mitomycin C and Bacillus Calmette-Guerin Instillation Therapy for Carcinoma in Situ of the Bladder
1995
Perioperative Single Dose Instillation of Epirubicin or Interferon-α After Transurethral Resection for The Prophylaxis of Primary Superficial Bladder Cancer Recurrence: A Prospective Randomized Multicenter Study—Finnbladder III Long-Term Results
2002
Intravesical Dimethyl Sulfoxide Instillations in the Treatment of Secondary Amyloidosis of the Bladder
1990
Alternating mitomycin C and bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the bladder. The Finnbladder Group.
1995
Perioperative single dose instillation of epirubicin or interferon-alpha after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a prospective randomized multicenter study--FinnBladder III long-term results.
2002